Efficacy and safety of bivalirudin without post-procedure infusion in patients with coronary heart disease during elective percutaneous coronary intervention: a real-world study.

Author: Ping WANG ¹ ; Xin ZHAO ² ; Qimin YUAN ¹ ; Xiaoxue YU ¹ ; Lin YANG ¹ ; Xiaozeng WANG ¹
Author Information

1. Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, Liaoning 110016, China.
2. Department of Cardiology, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116023, China.
Publication Type:Letter
MeSH: Anticoagulants; Antithrombins/therapeutic use*; Coronary Disease; Heparin; Hirudins; Humans; Peptide Fragments; Percutaneous Coronary Intervention; Recombinant Proteins; Treatment Outcome
From: Chinese Medical Journal 2021;135(1):116-118
CountryChina
Language:English